Profile Thera. Share Discussion Threads

[kombimatec] 18/3/2004 11:40

Will they benefit from the budget? R&D support annouced yesterday.

[zapa] 17/3/2004 20:08

preperation for Shares mag and IC I guess.

[ntv] 17/3/2004 19:44

nice rise today

[zapa] 15/3/2004 12:33

Quite pleased overall IC should give a good write up.

[ntv] 15/3/2004 12:21

promising results as prospects improving
once antibiotic inhaler gets going so should the shareprice

[ntv] 14/3/2004 22:36

results due tomorrow

[dad] 21/2/2004 11:07

Hopefully I have done this right. Targeting 72p as a get out.

Fingers, SuperMum, Cat would love your opinions.

Have a good weekend all,

Dad

[todworth] 20/2/2004 22:53

shall be keeping an eye in these.......with a view to buy at some point.

[zapa] 20/2/2004 20:22

MMakers in a muking fuddle over the prices wouldnt be suprised if monday brought a drop after the weekend buyers have bought,then back up as results get closer.

Anyhow good luck everyone I belive this management are very good but am concerned with ML laborotries and their click inhaler and if it will be a threat.

Any views?

[kombimatec] 19/2/2004 20:17

Shares magazine gave them a mention today.

[zapa] 19/2/2004 16:24

Doing well in the States having laid all the ground work with BREATH.

[kombimatec] 19/2/2004 16:13

More good news from PTP and they will continue to rise as they are exceeding their targets on sales and cashflow. The company is unusual in the pharma sector because it has an actual product.

[sse] 27/1/2004 22:10

Looks like a sell, but price held, there is much more life in this stock, some better volumes lately on up days. If Shares mag runs another piece as it did a couple of times last year (Tim Freeborn, generally positive, long term)then there should be some more upside.

SSE

[zapa] 27/1/2004 16:07

was that a sell 125000?

[ntv] 26/1/2004 09:46

still 2 cheap though

[ntv] 26/1/2004 09:45

looking better

[kombimatec] 12/1/2004 08:00

John Lisle stated in annual report the coming year was going to be pivotal. That must mean pivoting from losses in to profits.

[zapa] 12/1/2004 07:38

Good news from our company,brightened a dreary monday morning.

[beckaroo] 09/1/2004 08:36

From The Times today. See weblink.



AIM's Profile Therapeutics, the developer of inhaled drugs, added 5½p to 40p on confirming that first-half revenues are likely to be above £7 million. That gave Evolution Beeson Gregory confidence to repeat its £15.5 million full-year forecast and 42p target.

[ntv] 08/1/2004 17:14

still too cheap

[zapa] 08/1/2004 08:02

Agreed, one question though re M.L. Labs and their handheld.Is it in compatition with PTP?

[beckaroo] 08/1/2004 07:55

Excellent trading statement today derisking this investment. To me the major risks was the Prodose Handheld which is so important to their long term plans, so the statment :-

* Development of Prodose HandHeld has progressed successfully to the tooling
phase and the first units are planned to be with patients in the summer of 2004.

Makes me very happy. The sales ahead of planned (again) at 7 mil and the other news make this a great investment for the future.

[kombimatec] 05/1/2004 15:51

I've been holding since April 2002 @53p. Bought again later @36p but then got cold feet and sold some @26p. My remaining average is 44p so bought some more today @34,5p because I now feel they are ready to make some money in the foreseable future. This company does have a physical product to sell and that differs them from other pharma companies. I also know one of the directors(and that's why I bought them in the first place)and he is an impressive guy with his own money tied up in it. I know him well enough to know he wouldn't put money into anything without being 100% confident. We never discuss his involvement or the company it's just that I know his credentials and they are very good. I've just had to be a little more patient. I'll buy more at this price if poss.

[cbeadle] 02/1/2004 23:53

I have held since the summer not much action, but they seem to be completely overlooked